ONVO Organovo Holdings Inc

Price (delayed)

$3.55

Market cap

$30.92M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.32

Enterprise value

$4.29M

Organovo is an early-stage biotechnology company that is developing and utilizing highly customized 3D human tissues as dynamic models of healthy and diseased human biology for drug development. The company's ...

Highlights
The EPS has increased by 46% year-on-year and by 5% since the previous quarter
The net income is up by 32% year-on-year and by 6% since the previous quarter
ONVO's quick ratio has plunged by 60% YoY but it is up by 37% from the previous quarter
The equity has declined by 23% year-on-year and by 3.5% since the previous quarter

Key stats

What are the main financial stats of ONVO
Market
Shares outstanding
8.71M
Market cap
$30.92M
Enterprise value
$4.29M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.02
Price to sales (P/S)
20.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.86
Earnings
Revenue
$1.5M
EBIT
-$11.45M
EBITDA
-$11.3M
Free cash flow
-$8.86M
Per share
EPS
-$1.32
Free cash flow per share
-$1.02
Book value per share
$3.47
Revenue per share
$0.17
TBVPS
$3.83
Balance sheet
Total assets
$33.3M
Total liabilities
$3.09M
Debt
$2.18M
Equity
$30.21M
Working capital
$28.15M
Liquidity
Debt to equity
0.07
Current ratio
21.35
Quick ratio
20.84
Net debt/EBITDA
2.36
Margins
EBITDA margin
-753.6%
Gross margin
100%
Net margin
-763.2%
Operating margin
-765.3%
Efficiency
Return on assets
-32.1%
Return on equity
-34.4%
Return on invested capital
-389.9%
Return on capital employed
-35.9%
Return on sales
-763.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ONVO stock price

How has the Organovo Holdings stock price performed over time
Intraday
10.59%
1 week
21.99%
1 month
14.52%
1 year
-53.9%
YTD
-2.2%
QTD
100.56%

Financial performance

How have Organovo Holdings's revenue and profit performed over time
Revenue
$1.5M
Gross profit
$1.5M
Operating income
-$11.48M
Net income
-$11.45M
Gross margin
100%
Net margin
-763.2%
The net income is up by 32% year-on-year and by 6% since the previous quarter
The operating income has grown by 32% YoY and by 6% from the previous quarter

Growth

What is Organovo Holdings's growth rate over time

Valuation

What is Organovo Holdings stock price valuation
P/E
N/A
P/B
1.02
P/S
20.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.86
The EPS has increased by 46% year-on-year and by 5% since the previous quarter
The stock's price to book (P/B) is 63% less than its 5-year quarterly average of 2.5 and 38% less than its last 4 quarters average of 1.5
The equity has declined by 23% year-on-year and by 3.5% since the previous quarter

Efficiency

How efficient is Organovo Holdings business performance
ONVO's return on invested capital has surged by 66% year-on-year and by 34% since the previous quarter
ONVO's return on assets is up by 49% year-on-year
The ROE has grown by 47% YoY

Dividends

What is ONVO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ONVO.

Financial health

How did Organovo Holdings financials performed over time
ONVO's quick ratio has plunged by 60% YoY but it is up by 37% from the previous quarter
ONVO's current ratio has shrunk by 60% YoY but it is up by 37% QoQ
ONVO's debt is 93% smaller than its equity
The equity has declined by 23% year-on-year and by 3.5% since the previous quarter
ONVO's debt is down by 3.9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.